SHOP
Shop KapahuluShop KapoleiShop Kailua
RESOurces
Hawaii Medical Cannabis ProgramCertifying PhysiciansWellness GuideOther ResourcesVideosFAQ
ViSITORSYour 329 Card Roadmap
About
Our ProcessVideos
CONTACT
CareersGet In Touch
BLOG
 JOIN OUR LOYALTY PROGRAM
News

FDA And FTC Send Warning Letters About ‘Copycat’ Delta-8 THC Products Resembling Popular Food Brands Like Doritos

Jul 6, 2023
HomeBlogNews
Post
T

he Food and Drug Administration (FDA) and Federal Trade Commission (FTC) have teamed up to send warning letters to six companies that the agencies say are unlawfully selling “copycat” delta-8 THC products that are misleadingly packaged to mimic popular brands like Doritos, Cheetos and Jolly Ranchers.

The market for delta-8 THC and other novel cannabinoids has rapidly expanded in recent years following the legalization of hemp and its derivatives under the 2018 Farm Bill. FDA and FTC have generally exercised discretion in taking enforcement action against businesses that are selling products containing substances like CBD or delta-8, targeting those whose packaging or claims about medical benefits are especially misleading.

These latest warning letters focus on two areas of federal law. First, they allege violations of the Federal Food, Drug and Cosmetic Act (FDCA) because they contain the unapproved “additive” delta-8 tetrahydrocannabinol. The officials then detail what they call “copycat” products that are packaged in ways that resemble popular brands that could appeal to children and lead to accidental consumption of the intoxicating cannabinoid.

“Children are more vulnerable than adults to the effects of THC, with many who have been sickened and even hospitalized after eating ‘edibles’ containing it,” FDA Principal Deputy Commissioner Janet Woodcock said in a press release on Wednesday. “That’s why we’re issuing warnings to several companies selling copycat food products containing delta-8 THC, which can be easily mistaken for popular foods that are appealing to children and can make it easy for a young child to ingest in very high doses without realizing it.”

“The products we are warning against intentionally mimic well-known snack food brands by using similar brand names, logos, or pictures on packaging, that consumers, especially children, may confuse with traditional snack foods. We’re also concerned that adults could unintentionally take them or take a higher dose than expected and suffer serious consequences. This risk is especially dangerous for those who are driving, working, or have other responsibilities. The FDA remains committed to taking action against any company illegally selling regulated products that could pose a risk to public health.”

The companies that received the warning letters are Delta Munchies, Dr. Smoke LLC, Exclusive Hemp Farms/Oshipt, Nikte’s Wholesale LLC, North Carolina Hemp Exchange LLC and The Haunted Vapor Room.

FDA said it has received reports of “serious adverse events” experienced by people who consumed delta-8 products, adding that it is “also concerned that companies are producing delta-8 THC in ways that could result in products with harmful contaminants.”

FDA sent a first batch of warning letters regarding delta-8 THC products last year, publicizing information about what it described as unsanctioned medical claims about the items. For this round, FTC also weighed in, focusing on alleged violations related to “copycat” marketing.

“Marketing edible THC products that can be easily mistaken by children for regular foods is reckless and illegal,” Samuel Levine, director of the FTC’s Bureau of Consumer Protection, said. “Companies must ensure that their products are marketed safely and responsibly, especially when it comes to protecting the well-being of children.”

The businesses that received the letters must respond to both agencies within 15 days to either contest the claims or outline what they are doing to cease sales of the specific products and get into compliance. “Failure to promptly address the violations may result in legal action, including product seizure and/or injunction,” FDA said.

While FDA is taking the enforcement action against a limited number of businesses, it continues to face criticism over its decision not to enact regulations to allow for the lawful marketing of CBD in the food supply or as dietary supplements. The agency said that such rulemaking will require congressional attention.

‍

Tagged:
News
Stay in Touch

Subscribe to our newsletter to receive new posts straight to your inbox 👇

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CURE OAHU REVIEWS
Cureoahu logo
Tel: (808) 208-8770
E-mail: info@cureoahu.com
Hours: Mon - Sat 10:00am - 7:00pm Sun 11:00am - 5:00pm
Closed on: New Years Day, Thanksgiving, Christmas
‍
WAIKIKI
727 Kapahulu Ave
Honolulu, HI 96816

KAPOLEI
4850 Kapolei Pkwy, Bldg. D, #501
Kapolei, HI 96707

KAILUA
70 Kihapai Street
Kailua, HI 96734
© Copyright 2024 Cure Oahu. All Rights Reserved
Privacy PolicyTerms Contact UsWellness Guide